Mexico Wound Care Management Industry Report: Detailed Analysis of the Medical Equipment & Medical Devices Market Covering Advanced and Traditional Wound Management, Compression Therapy, Ostomy and Wound Closure Devices Medical Equipment and Supplies

Mexico Wound Care Management Industry Report: Detailed Analysis of the Medical Equipment & Medical Devices Market Covering Advanced and Traditional Wound Management, Compression Therapy, Ostomy and Wound Closure Devices Medical Equipment and Supplies

Mexico Wound Care Management Medical Equipment Industry Report

Summary

This report is an essential source for in-depth information and data relating to Mexico wound care management medical equipment market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the wound care management in Mexico

Scope

• The report provides sector information broken down into detailed categories and segments in country.
• Total revenues, products sold, end users, and average pricing.
• Market shares of all the key competitors.
• Key pipeline products that are set to shape the market, broken down by sector.
• Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
• Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
• Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
• Key mergers and acquisitions, partnerships, private equity investments and IPOs.
• Customer, hospitals and physicians data.

Reasons to buy

• Gain a strong understanding of the industry at a global level, with break downs for the country
• Evaluate and compare the attractiveness of the market in the country.
• Identify growth segments and opportunities in each industry sector within the country.
• Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
• Analyze the competitiveness of the market in the country and identify hotspots.
• Develop strategies based on the latest product, brand, expansion and research and development news in the country.
• Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
• Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

1 Table of Contents 2
1.1 List of Tables 11
1.2 List of Figures 14
2 Introduction 16
2.1 What Is This Report About? 16
2.2 Definitions 16
2.2.1 Wound Care Management 16
3 Healthcare Sector Review 18
4 Wound Care Management in Mexico 19
4.1 Wound Care Management Overall Revenues (2000-2012) 19
4.2 Wound Care Management Overall Volume (2000-2012) 25
4.3 Wound Care Management Overall Company Shares (2005-2006) 28
5 Wound Closure Devices in Mexico 29
5.1 Wound Closure Devices Overall Revenues (2000-2012) 29
5.1.1 Skin Closure Devices Overall Revenues (2000-2012) 33
5.1.2 Hemostats Overall Revenues (2000-2012) 35
5.1.3 Tissue Sealants Overall Revenues (2000-2012) 37
5.2 Wound Closure Devices Overall Volume (2000-2012) 39
5.2.1 Skin Closure Devices Overall Volume (2000-2012) 41
5.2.2 Hemostats Overall Volume (2000-2012) 43
5.2.3 Tissue Sealants Overall Volume (2000-2012) 45
5.3 Wound Closure Devices Average Price (2000-2012) 47
5.3.1 Hemostats Average Price (2000-2012) 47
5.3.2 Tissue Sealants Average Price (2000-2012) 49
5.3.3 Skin Closure Devices Average Price (2000-2012) 51
5.4 Wound Closure Devices Distribution Share (2005-2006) 53
5.5 Wound Closure Devices Company Share (2005-2006) 54
6 Ostomy in Mexico 55
6.1 Ostomy Overall Revenue (2000-2012) 55
6.2 Ostomy Overall Volume (2000-2012) 57
6.3 Ostomy Average Price (2000-2012) 59
6.4 Ostomy Distribution Share (2005-2006) 61
6.5 Ostomy Company Share (2005-2006) 62
7 Advanced Wound Management in Mexico 63
7.1 Advanced Wound Management Overall Revenue (2000-2012) 63
7.2 Advanced Wound Management Overall Volume (2000-2012) 65
7.3 Advanced Wound Management Average Price (2000-2012) 67
7.4 Advanced Wound Management Distribution Share (2005-2006) 69
7.5 Advanced Wound Management Company Share (2005-2006) 70
8 Traditional Wound Management in Mexico 71
8.1 Traditional Wound Management Overall Revenue (2000-2012) 71
8.2 Traditional Wound Management Overall Volume (2000-2012) 73
8.3 Traditional Wound Management Average Price (2000-2012) 75
8.4 Traditional Wound Management Distribution Share (2005-2006)) 77
8.5 Traditional Wound Management Company Share (2005-2006) 78
9 Compression Therapy in Mexico 79
9.1 Compression Therapy Overall Revenue (2000-2012) 79
9.2 Compression Therapy Overall Volume (2000-2012) 81
9.3 Compression Therapy Average Price (2000-2012) 83
9.4 Compression Therapy Distribution Share (2005-2006) 85
9.5 Compression Therapy Company Share (2005-2006) 86
10 Baxter International Company Profile 87
10.1 Company Overview 87
10.2 Business Overview 87
10.2.1 BioScience 87
10.2.2 Medication Delivery 87
10.2.3 Renal 88
10.2.4 Products 88
10.2.5 History 89
10.3 Value Chain Analysis 92
10.3.1 Manufacturing 92
10.3.2 Product Development 92
10.3.3 Sales and Marketing 93
10.4 SWOT Analysis 94
10.4.1 Baxter International Inc. Strengths 94
10.4.2 Baxter International Inc. Weaknesses 95
10.4.3 Baxter International Inc. Opportunities 95
10.4.4 Baxter International Inc. Threats 95
10.5 Financial and Operational Review 96
10.6 Locations And Subsidiaries 97
10.7 Financial Deals Landscape 99
10.7.1 Baiyunshan And Baxter Form A Joint Venture In China 99
10.7.2 Baxter Signs Licensing Agreement With Intercytex And Spinal Restoration 101
10.7.3 Baxter Sells Transfusion Therapies Business to Texas Pacific and Maverick Capital 102
10.7.4 B. Braun Acquires Renal Therapy Business Of Baxter 104
10.7.5 Innovata signs a license agreement with Baxter International 106
10.7.6 Kuros Biosurgery Signs An Agreement With Baxter International 107
10.7.7 Gambro Signs An Agreement With Baxter 109
10.7.8 Baxter Healthcare And Gambro Enter Into An Agreement 110
10.7.9 Baxter and Cerus Enter Into Agreement With BioOne for Commercialization Of INTERCEPT Blood System 112
10.7.10 Baxter International And Kaketsuken Enter Into Agreement 114
10.7.11 Baxter To Acquire 40% Stake In Shanghai Baxter From Worldbest Treeful 115
10.8 Recent Developments 116
10.8.1 Jan 24, 2008: Baxter Achieves Record Sales and Earnings for Full-Year 2007 116
10.8.2 Dec 18, 2007: Baxter Elects CFO 118
10.8.3 Nov 13, 2007: Baxter Declares Quarterly Dividend 119
10.8.4 Aug 01, 2007: Baxter Elects New Board Director 119
10.8.5 Jul 31, 2007: Baxter Announces Quarterly Dividend 119
10.8.6 Mar 13, 2007: Baxter Declares Additional Share Repurchase Authorization 119
10.8.7 Feb 13, 2007: Baxter Announces Quarterly Dividend 120
10.8.8 Nov 28, 2006: Baxter Announces Annual Dividend 120
10.8.9 Sep 14, 2006: Baxter Appoints President, Baxter Latin America 120
10.9 Baxter International Inc. Pipeline Products 121
10.9.1 Next-Generation Home Hemodialysis Machine 121
11 Covidien Ltd./Tyco Healthcare Company Profile 123
11.1 Company Overview 123
11.2 Business Overview 123
11.2.1 Imaging Solutions 123
11.2.2 Medical Devices 124
11.2.3 Medical Supplies 124
11.2.4 Pharmaceutical Products 125
11.2.5 Retail Products 125
11.2.6 Products 126
11.2.7 History 126
11.3 Value Chain Analysis 127
11.3.1 Manufacturing 128
11.3.2 Product Development 128
11.3.3 Sales and Marketing 129
11.4 SWOT Analysis 129
11.4.1 Covidien Ltd./Tyco Healthcare Strengths 130
11.4.2 Covidien Ltd./Tyco Healthcare Weaknesses 131
11.4.3 Covidien Ltd./Tyco Healthcare Opportunities 132
11.4.4 Covidien Ltd./Tyco Healthcare Threats 132
11.5 Financial and Operational Review 134
11.5.1 Financial Statements 134
11.5.2 Financial Ratios 135
11.6 Locations And Subsidiaries 136
11.7 Financial Deals Landscape 138
11.7.1 Covidien Signs An Agreement With Allergan 138
11.7.2 Covidien Acquires Scandius Biomedical 139
11.7.3 Covidien International Finance Completes Private Placement Of $2,750 Million 140
11.7.4 Covidien And BioSynthema Enter Into Licensing Agreement 142
11.7.5 Integra LifeSciences Acquires Assets Of Radionics Division From Covidien 143
11.7.6 Covidien To Sell European Incontinence Business 145
11.7.7 Covidien To Acquire Tissue Science Laboratories 147
11.8 Recent Developments 148
11.8.1 Mar 28, 2008: Covidien Spends $760,000 Lobbying Federal Government In 2007 148
11.8.2 Mar 18, 2008: Covidien Declares Quarterly Dividend 149
11.8.3 Feb 21, 2008: Covidien Gests Favorable Decision In Patent Litigation Case 149
11.8.4 Feb 07, 2008: Covidien Declares Q1 Fiscal 2008 Results 149
11.8.5 Jan 15, 2008: Covidien Declares Quarterly Dividend 151
11.8.6 Jan 10, 2008: Covidien To Declare Q1 Fiscal 2008 Results 151
11.8.7 Dec 06, 2007: Covidien Reports Q4 Fiscal 2007 Results 151
11.8.8 Oct 04, 2007: Covidien And NewSouth Innovations Collaborate To Develop Novel Imaging Agent 153
11.8.9 Sep 28, 2007: Covidien Declares Quarterly Dividend 153
11.8.10 Aug 09, 2007: Covidien Declares Q3 Fiscal 2007 Results 153
11.9 Covidien Ltd./Tyco Healthcare Pipeline Products 155
11.9.1 PleuraSeal Lung Sealant System 155
11.9.2 Sandman Intro CPAP Device 156
12 3M Company Profile 158
12.1 Company Overview 158
12.2 Business Overview 158
12.2.1 Consumer and Office 158
12.2.2 Display and Graphics 158
12.2.3 Electro and Communications 159
12.2.4 Health Care 159
12.2.5 Industrial and Transportation 160
12.2.6 Safety, Security and Protection Services 161
12.2.7 Products 161
12.3 Value Chain Analysis 163
12.3.1 Manufacturing 163
12.3.2 Product Development 164
12.3.3 Sales and Marketing 164
12.4 SWOT Analysis 165
12.4.1 3M Company Strengths 165
12.4.2 3M Company Weaknesses 166
12.4.3 3M Company Opportunities 166
12.4.4 3M Company Threats 167
12.5 Financial and Operational Review 168
12.6 Locations And Subsidiaries 169
12.6.1 Other Locations & Subsidiaries 170
12.7 Financial Deals Landscape 171
12.7.1 3M Canada Acquires Les Entreprises Solumed 171
12.7.2 3M Acquires Bondo 172
12.7.3 3M Acquires Lingualcare 174
12.7.4 3M Acquires Abzil Industria E Comercio 176
12.7.5 3M Acquires Neo Plast 178
12.7.6 3M Acquires Assets Of DMS Chile 180
12.7.7 3M Acquires Business Of Innovative Paper Technologies 182
12.7.8 3M Acquires Powell 184
12.7.9 Gen-Probe Signs An Agreement With 3M Company 186
12.7.10 3M Acquires Acolyte Biomedica 188
12.7.11 3M Acquires Sealed Air Corp.'S Interest In Polymask Corp. 190
12.7.12 3M Sells Its Pharmaceutical Business To Meda AB 192
12.7.13 3M Acquires SoftMed Systems 194
12.7.14 3M Sells its Pharmaceuticals Business to Graceway 196
12.7.15 Gen-Probe Signs An Agreement With 3M 198
12.7.16 3M Sells its Pharmaceutical Operations in the Asia Pacific Region to Ironbridge Capital and Archer Capital 200
12.7.17 3M Acquires Biotrace International 202
12.7.18 Ekahau Secures $16 Million In Additional Funding 204
12.7.19 3M Acquires Brontes Technologies 207
12.7.20 3M acquires Nylonge Corp 209
12.7.21 3M Signs An Agreement With ClozeX Medical 211
12.7.22 3M Acquires OMNII Oral Pharmaceuticals 213
12.7.23 3M Sells Pharmaceutical Operations In The United States To Graceway 215
12.7.24 3M Sells Pharmaceutical Business In Europe To Meda AB 217
12.7.25 3M Sells Pharmaceutical Operations In The Asia Pacific To Ironbridge and Archer Capital 220
12.7.26 3M Acquires Accuspray Application Technologies Inc. 222
12.7.27 3M to acquire Rochford Thompson Equipment 224
12.7.28 3M To Acquire Aearo Technologies From Permira 226
12.7.29 Permira To Sell Aearo Technologies To 3M 228
12.8 Recent Developments 231
12.8.1 Mar 31, 2008: HighJump Software Introduces Survey Management Solution for Direct Store Delivery Businesses 231
12.8.2 Mar 24, 2008: Brazil's Companhia de Transmissao de Energia Eletrica Paulista Chooses 3M ACCR for Upgrade of Line Over Parana River in Sao Paulo State 231
12.8.3 Mar 19, 2008: 3M to Headquarter Optical Systems Business in Asia 233
12.8.4 Mar 19, 2008: 3M To Headquarter Optical Systems Business In North Asia 233
12.8.5 Feb 11, 2008: 3M Increases Dividend for the 50th Straight Year 233
12.8.6 Nov 12, 2007: 3M Declares Quarterly Dividend 233
12.8.7 Oct 24, 2007: 3M And Sanyo Settle Suit On Lithium Ion Battery 233
12.8.8 Aug 13, 2007: 3M Declares Quarterly Dividend 234
12.8.9 May 08, 2007: 3M Declares Quarterly Dividend 234
12.8.10 Apr 30, 2007: Gen-Probe And 3M Collaborate To Develop Rapid Molecular Tests 234
13 Ethicon, Inc. Company Profile 235
13.1 Company Overview 235
13.2 Business Overview 235
13.2.1 Products 236
13.3 Locations And Subsidiaries 236
13.4 Financial Deals Landscape 238
13.4.1 Edwards Lifesciences Acquires CardioVations Product Line From ETHICON 238
13.4.2 Musculoskeletal Transplant Signs Marketing Agreement With ETHICON 240
13.4.3 ETHICON Acquires Vascular Control Systems 241
13.4.4 Datascope Acquires Endoscopic Vessel Harvesting Business From ETHICON 242
14 Smith & Nephew Plc Company Profile 245
14.1 Company Overview 245
14.2 Business Overview 245
14.2.1 Advanced Wound Management 245
14.2.2 Endoscopy 245
14.2.3 Reconstruction 246
14.2.4 Trauma and Clinical Therapies 247
14.2.5 Products 247
14.2.6 History 248
14.3 Value Chain Analysis 252
14.3.1 Manufacturing 252
14.3.2 Product Development 253
14.3.3 Sales and Marketing 254
14.4 SWOT Analysis 254
14.4.1 Smith & Nephew Plc Strengths 254
14.4.2 Smith & Nephew Plc Weaknesses 255
14.4.3 Smith & Nephew Plc Opportunities 255
14.4.4 Smith & Nephew Plc Threats 256
14.5 Financial and Operational Review 257
14.6 Locations And Subsidiaries 258
14.7 Financial Deals Landscape 260
14.7.1 Smith & Nephew Endoscopy Sells Its Vascular Business To InaVein 260
14.7.2 Smith & Nephew Signs An Agreement With Universal Hospital Services 260
14.7.3 Smith & Nephew Acquires Plus Orthopedics Holding 261
14.7.4 Smith & Nephew And Teknimed Enter Into Distribution Agreement 262
14.7.5 Smith & Nephew Acquires BlueSky Medical Group 263
14.7.6 Smith & Nephew Enters Into An Agreement With Covalon 264
14.7.7 Smith & Nephew Signs An Agreement With UDL Laboratories 265
14.7.8 Nexa Orthopedics Signs An Agreement With Smith & Nephew 266
14.7.9 Smith & Nephew Acquires Osteobiologics 267
14.7.10 Smith & Nephew And Q-MED Enter Into Licensing Agreement 268
14.7.11 Smith & Nephew Completes Sale Of 50% Interest In BSN Medical To Montagu Private Equity 269
14.7.12 ArthroCare Enters Into Licensing Agreement With Smith & Nephew 270
14.7.13 Smith & Nephew Signs Licensing Agreement With Alexandria Research Technologies 271
14.7.14 Smith & Nephew Signs An Agreement With ORTHOsoft 272
14.7.15 Osteotech And Smith & Nephew Enter Into Processing And Distribution Agreement 273
14.7.16 Smith & Nephew Acquires VERSAJET From HydroCision 274
14.7.17 Smith & Nephew Terminates Acquisition Of Biomet 275
14.8 Recent Developments 276
14.8.1 Apr 02, 2008: Smith & Nephew Declares Second Interim Dividend 276
14.8.2 Apr 02, 2008: Smith & Nephew Reports 2007 Results 276
14.8.3 Mar 23, 2008: Smith & Nephew, Corin Battle To Win Over America’s Hip Generation 278
14.8.4 Feb 29, 2008: Smith & Nephew Appoints SVP, GM 278
14.8.5 Feb 20, 2008: Smith & Nephew and Synthes Settle Patent Dispute For Trochanteric Fixation Nails 279
14.8.6 Oct 22, 2007: Smith & Nephew Declares Interim Dividend 279
14.8.7 May 03, 2007: Smith & Nephew Appoints New CEO 279
14.9 Smith & Nephew Plc Pipeline Products 280
14.9.1 R3 Modular resurfacing Acetabular system 280
14.9.2 R3 Ceramic-on-ceramic Acetabular System 280
15 Regulation System 282
15.1 Device Classification 282
15.2 Registration Process 282
15.3 Labeling Requirements 284
15.4 Import Documentation 285
16 Pricing and Reimbursement 286
17 Distribution Structure 287
18 APPENDIX 288
18.1 Global Markets Direct Research Methodology 288
18.2 Coverage 289
18.3 Secondary Research 289
18.4 Primary Research 290
18.5 Models 290
18.6 Forecasts 291
18.7 Expert Panels 291
18.8 Currency Conversion 292
18.9 Contact Us 293
18.10 Disclaimer 293



1.1 List of Tables
Table 1: Wound Care Management, Mexico, Overall Revenues ($ mn), 2000-2012 19
Table 2: Wound Care Management, Mexico, Overall Revenues ($ mn), Historic, 2000-2007 20
Table 3: Wound Care Management, Mexico, Overall Revenues ($ mn), Forecast, 2007-2012 21
Table 4: Wound Care Management, Mexico, Category Revenues ($ mn), 2000-2012 22
Table 5: Wound Care Management, Mexico, Category Revenues ($ mn), Historic, 2000-2007 23
Table 6: Wound Care Management, Mexico, Category Revenues ($ mn), Forecast, 2007-2012 24
Table 7: Wound Care Management, Mexico, Category Volume (Units), 2000-2012 25
Table 8: Wound Care Management, Mexico, Category Volume (Units), Historic, 2000-2007 26
Table 9: Wound Care Management, Mexico, Category Volume (Units), Forecast, 2007-2012 27
Table 10: Wound Care Management, Mexico, Overall Company Share by Revenue ($ mn), 2005-2006 28
Table 11: Wound Closure Devices, Mexico, Overall Revenues ($ mn), Historic, 2000-2007 29
Table 12: Wound Closure Devices, Mexico, Overall Revenues ($ mn), Forecast, 2007-2012 30
Table 13: Wound Closure Devices, Mexico, Revenue by Segment ($ mn), Historic, 2000-2007 31
Table 14: Wound Closure Devices, Mexico, Revenue by Segment ($ mn), Forecast, 2007-2012 32
Table 15: Skin Closure Devices, Mexico, Overall Revenues ($ mn), Historic, 2000-2007 33
Table 16: Skin Closure Devices, Mexico, Overall Revenues ($ mn), Forecast, 2007-2012 34
Table 17: Hemostats, Mexico, Overall Revenues ($ mn), Historic, 2000-2007 35
Table 18: Hemostats, Mexico, Overall Revenues ($ mn), Forecast, 2007-2012 36
Table 19: Tissue Sealants, Mexico, Overall Revenues ($ mn), Historic, 2000-2007 37
Table 20: Tissue Sealants, Mexico, Overall Revenues ($ mn), Forecast, 2007-2012 38
Table 21: Wound Closure Devices, Mexico, Overall Volume (Units), Historic, 2000-2007 39
Table 22: Wound Closure Devices, Mexico, Overall Volume (Units), Forecast, 2007-2012 40
Table 23: Skin Closure Devices, Mexico, Overall Volume (Units), Historic, 2000-2007 41
Table 24: Skin Closure Devices, Mexico, Overall Volume (Units), Forecast, 2007-2012 42
Table 25: Hemostats, Mexico, Overall Volume (Units), Historic, 2000-2007 43
Table 26: Hemostats, Mexico, Overall Volume (Units), Forecast, 2007-2012 44
Table 27: Tissue Sealants, Mexico, Overall Volume (Units), Historic, 2000-2007 45
Table 28: Tissue Sealants, Mexico, Overall Volume (Units), Forecast, 2007-2012 46
Table 29: Hemostats, Mexico, Average Price ($), Historic, 2000-2007 47
Table 30: Hemostats, Mexico, Average Price ($), Forecast, 2007-2012 48
Table 31: Tissue Sealants, Mexico, Average Price ($), Historic, 2000-2007 49
Table 32: Tissue Sealants, Mexico, Average Price ($), Forecast, 2007-2012 50
Table 33: Skin Closure Devices, Mexico, Average Price ($), Historic, 2000-2007 51
Table 34: Skin Closure Devices, Mexico, Average Price ($), Forecast, 2007-2012 52
Table 35: Wound Closure Devices, Mexico, Distribution Share by Revenue ($ mn), 2005-2006 53
Table 36: Wound Closure Devices, Mexico, Company Share by Revenue ($ mn), 2005-2006 54
Table 37: Ostomy, Mexico, Overall Revenues ($ mn), Historic, 2000-2007 55
Table 38: Ostomy, Mexico, Overall Revenues ($ mn), Forecast, 2007-2012 56
Table 39: Ostomy, Mexico, Overall Volume (Units), Historic, 2000-2007 57
Table 40: Ostomy, Mexico, Overall Volume (Units), Forecast, 2007-2012 58
Table 41: Ostomy, Mexico, Average Price ($), Historic, 2000-2007 59
Table 42: Ostomy, Mexico, Average Price ($), Forecast, 2007-2012 60
Table 43: Ostomy, Mexico, Distribution Share by Revenue ($ mn), 2005-2006 61
Table 44: Ostomy, Mexico, Company Share by Revenue ($ mn), 2005-2006 62
Table 45: Advanced Wound Management, Mexico, Overall Revenues ($ mn), Historic, 2000-2007 63
Table 46: Advanced Wound Management, Mexico, Overall Revenues ($ mn), Forecast, 2007-2012 64
Table 47: Advanced Wound Management, Mexico, Overall Volume (Units), Historic, 2000-2007 65
Table 48: Advanced Wound Management, Mexico, Overall Volume (Units), Forecast, 2007-2012 66
Table 49: Advanced Wound Management, Mexico, Average Price ($), Historic, 2000-2007 67
Table 50: Advanced Wound Management, Mexico, Average Price ($), Forecast, 2007-2012 68
Table 51: Advanced Wound Management, Mexico, Distribution Share by Revenue ($ mn), 2005-2006 69
Table 52: Advanced Wound Management, Mexico, Company Share by Revenue ($ mn), 2005-2006 70
Table 53: Traditional Wound Management, Mexico, Overall Revenues ($ mn), Historic, 2000-2007 71
Table 54: Traditional Wound Management, Mexico, Overall Revenues ($ mn), Forecast, 2007-2012 72
Table 55: Traditional Wound Management, Mexico, Overall Volume (Units), Historic, 2000-2007 73
Table 56: Traditional Wound Management, Mexico, Overall Volume (Units), Forecast, 2007-2012 74
Table 57: Traditional Wound Management, Mexico, Average Price ($), Historic, 2000-2007 75
Table 58: Traditional Wound Management, Mexico, Average Price ($), Forecast, 2007-2012 76
Table 59: Traditional Wound Management, Mexico, Distribution Share by Revenue ($ mn), 2005-2006 77
Table 60: Traditional Wound Management, Mexico, Company Share by Revenue ($ mn), 2005-2006 78
Table 61: Compression Therapy, Mexico, Overall Revenues ($ mn), Historic, 2000-2007 79
Table 62: Compression Therapy, Mexico, Overall Revenues ($ mn), Forecast, 2007-2012 80
Table 63: Compression Therapy, Mexico, Overall Volume (Units), Historic, 2000-2007 81
Table 64: Compression Therapy, Mexico, Overall Volume (Units), Forecast, 2007-2012 82
Table 65: Compression Therapy, Mexico, Average Price ($), Historic, 2000-2007 83
Table 66: Compression Therapy, Mexico, Average Price ($), Forecast, 2007-2012 84
Table 67: Compression Therapy, Mexico, Distribution Share by Revenue ($ mn), 2005-2006 85
Table 68: Compression Therapy, Mexico, Company Share by Revenue ($ mn), 2005-2006 86
Table 69: Baxter International Inc., SWOT Analysis, 2006 94
Table 70: Baxter International Inc., Financial Statements, USD Million, 2002-2006 96
Table 71: Baxter International Inc., Financial Ratios, USD Million, 2002-2006 97
Table 72: Baxter International Inc., Other Locations 98
Table 73: Baxter International Inc., Subsidiaries 99
Table 74: Covidien Ltd./Tyco Healthcare, SWOT Analysis, 2007 130
Table 75: Covidien Ltd./Tyco Healthcare, Financial Statements, USD Million, 2003-2007 134
Table 76: Covidien Ltd./Tyco Healthcare, Financial Ratios, USD Million, 2003-2007 135
Table 77: Covidien Ltd./Tyco Healthcare, Other Locations 136
Table 78: Covidien Ltd./Tyco Healthcare, Subsidiaries 137
Table 79: 3M Company, SWOT Analysis, 2006 165
Table 80: 3M Company, Financial Statements, USD Million, 2002-2006 168
Table 81: 3M Company, Financial and Operational Overview, USD Million, 2002-2006 169
Table 82: 3M Company, Subsidiaries 170
Table 83: Ethicon, Inc., Other Locations 237
Table 84: Ethicon, Inc., Subsidiaries 237
Table 85: Smith & Nephew Plc, SWOT Analysis, 2006 254
Table 86: Smith & Nephew Plc, Financial Statements, USD Million, 2002-2006 257
Table 87: Smith & Nephew Plc, Financial Ratios, USD Million, 2002-2006 258
Table 88: Smith & Nephew Plc, Other Locations 259
Table 89: Currency Conversion from USD to Local Currency at 2007 Constant Rate 292



1.1 List of Figures
Figure 1: Wound Care Management, Mexico, Overall Revenues ($ mn), 2000-2012 19
Figure 2: Wound Care Management, Mexico, Overall Revenues ($ mn), Historic, 2000-2007 20
Figure 3: Wound Care Management, Mexico, Overall Revenues ($ mn), Forecast, 2007-2012 21
Figure 4: Wound Care Management, Mexico, Category Revenues ($ mn), 2000-2012 22
Figure 5: Wound Care Management, Mexico, Category Revenues ($ mn), Historic, 2000-2007 23
Figure 6: Wound Care Management, Mexico, Category Revenues ($ mn), Forecast, 2007-2012 24
Figure 7: Wound Care Management, Mexico, Category Volume (Units), 2000-2012 25
Figure 8: Wound Care Management, Mexico, Category Volume (Units), Historic, 2000-2007 26
Figure 9: Wound Care Management, Mexico, Category Volume (Units), Forecast, 2007-2012 27
Figure 10: Wound Care Management, Mexico, Overall Company Share (%), 2006 28
Figure 11: Wound Closure Devices, Mexico, Overall Revenues ($ mn), Historic, 2000-2007 29
Figure 12: Wound Closure Devices, Mexico, Overall Revenues ($ mn), Forecast, 2007-2012 30
Figure 13: Wound Closure Devices, Mexico, Revenue by Segment ($ mn), Historic, 2000-2007 31
Figure 14: Wound Closure Devices, Mexico, Revenue by Segment ($ mn), Forecast, 2007-2012 32
Figure 15: Skin Closure Devices, Mexico, Overall Revenues ($ mn), Historic, 2000-2007 33
Figure 16: Skin Closure Devices, Mexico, Overall Revenues ($ mn), Forecast, 2007-2012 34
Figure 17: Hemostats, Mexico, Overall Revenues ($ mn), Historic, 2000-2007 35
Figure 18: Hemostats, Mexico, Overall Revenues ($ mn), Forecast, 2007-2012 36
Figure 19: Tissue Sealants, Mexico, Overall Revenues ($ mn), Historic, 2000-2007 37
Figure 20: Tissue Sealants, Mexico, Overall Revenues ($ mn), Forecast, 2007-2012 38
Figure 21: Wound Closure Devices, Mexico, Overall Volume (Units), Historic, 2000-2007 39
Figure 22: Wound Closure Devices, Mexico, Overall Volume (Units), Forecast, 2007-2012 40
Figure 23: Skin Closure Devices, Mexico, Overall Volume (Units), Historic, 2000-2007 41
Figure 24: Skin Closure Devices, Mexico, Overall Volume (Units), Forecast, 2007-2012 42
Figure 25: Hemostats, Mexico, Overall Volume (Units), Historic, 2000-2007 43
Figure 26: Hemostats, Mexico, Overall Volume (Units), Forecast, 2007-2012 44
Figure 27: Tissue Sealants, Mexico, Overall Volume (Units), Historic, 2000-2007 45
Figure 28: Tissue Sealants, Mexico, Overall Volume (Units), Forecast, 2007-2012 46
Figure 29: Hemostats, Mexico, Average Price ($), Historic, 2000-2007 47
Figure 30: Hemostats, Mexico, Average Price ($), Forecast, 2007-2012 48
Figure 31: Tissue Sealants, Mexico, Average Price ($), Historic, 2000-2007 49
Figure 32: Tissue Sealants, Mexico, Average Price ($), Forecast, 2007-2012 50
Figure 33: Skin Closure Devices, Mexico, Average Price ($), Historic, 2000-2007 51
Figure 34: Skin Closure Devices, Mexico, Average Price ($), Forecast, 2007-2012 52
Figure 35: Wound Closure Devices, Mexico, Distribution Share (%), 2006 53
Figure 36: Wound Closure Devices, Mexico, Company Share (%), 2006 54
Figure 37: Ostomy, Mexico, Overall Revenues ($ mn), Historic, 2000-2007 55
Figure 38: Ostomy, Mexico, Overall Revenues ($ mn), Forecast, 2007-2012 56
Figure 39: Ostomy, Mexico, Overall Volume (Units), Historic, 2000-2007 57
Figure 40: Ostomy, Mexico, Overall Volume (Units), Forecast, 2007-2012 58
Figure 41: Ostomy, Mexico, Average Price ($), Historic, 2000-2007 59
Figure 42: Ostomy, Mexico, Average Price ($), Forecast, 2007-2012 60
Figure 43: Ostomy, Mexico, Company Share (%), 2006 62
Figure 44: Advanced Wound Management, Mexico, Overall Revenues ($ mn), Historic, 2000-2007 63
Figure 45: Advanced Wound Management, Mexico, Overall Revenues ($ mn), Forecast, 2007-2012 64
Figure 46: Advanced Wound Management, Mexico, Overall Volume (Units), Historic, 2000-2007 65
Figure 47: Advanced Wound Management, Mexico, Overall Volume (Units), Forecast, 2007-2012 66
Figure 48: Advanced Wound Management, Mexico, Average Price ($), Historic, 2000-2007 67
Figure 49: Advanced Wound Management, Mexico, Average Price ($), Forecast, 2007-2012 68
Figure 50: Advanced Wound Management, Mexico, Distribution Share (%), 2006 69
Figure 51: Advanced Wound Management, Mexico, Company Share (%), 2006 70
Figure 52: Traditional Wound Management, Mexico, Overall Revenues ($ mn), Historic, 2000-2007 71
Figure 53: Traditional Wound Management, Mexico, Overall Revenues ($ mn), Forecast, 2007-2012 72
Figure 54: Traditional Wound Management, Mexico, Overall Volume (Units), Historic, 2000-2007 73
Figure 55: Traditional Wound Management, Mexico, Overall Volume (Units), Forecast, 2007-2012 74
Figure 56: Traditional Wound Management, Mexico, Average Price ($), Historic, 2000-2007 75
Figure 57: Traditional Wound Management, Mexico, Average Price ($), Forecast, 2007-2012 76
Figure 58: Traditional Wound Management, Mexico, Distribution Share (%), 2006 77
Figure 59: Traditional Wound Management, Mexico, Company Share (%), 2006 78
Figure 60: Compression Therapy, Mexico, Overall Revenues ($ mn), Historic, 2000-2007 79
Figure 61: Compression Therapy, Mexico, Overall Revenues ($ mn), Forecast, 2007-2012 80
Figure 62: Compression Therapy, Mexico, Overall Volume (Units), Historic, 2000-2007 81
Figure 63: Compression Therapy, Mexico, Overall Volume (Units), Forecast, 2007-2012 82
Figure 64: Compression Therapy, Mexico, Average Price ($), Historic, 2000-2007 83
Figure 65: Compression Therapy, Mexico, Average Price ($), Forecast, 2007-2012 84
Figure 66: Compression Therapy, Mexico, Distribution Share (%), 2006 85
Figure 67: Compression Therapy, Mexico, Company Share (%), 2006 86
Figure 68: Baxter International Inc., Value Chain Analysis 92
Figure 69: Covidien Ltd./Tyco Healthcare, Value Chain Analysis 127
Figure 70: 3M Company, Value Chain Analysis 163
Figure 71: Smith & Nephew Plc, Value Chain Analysis 252
Figure 72: Global Markets Direct Methodology 288